Concepedia

Anlai Wang

AW

30

Publications

2.2K

Citations

21

H-Index

1987

Active since

Affiliations

Incyte (United States)(Current)

Experimental Station

Millennium Engineering and Integration (United States)

Sanofi (France)

Sanofi (United States)

Anlai Wang is an author at Incyte (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1987–2023

30

Publications

30

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Silvia Buonamici, Juliet Williams, Michael Morrissey et al. · Science Translational Medicine · 2010 · 553 citations

Functional Isolation and Characterization of Human Hematopoietic Stem Cells

Anna C. Berardi, Anlai Wang, James D. Levine et al. · Science · 1995 · 404 citations

Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344

Carrie Brodmerkel, Reid Huber, Maryanne Covington et al. · The Journal of Immunology · 2005 · 187 citations

, , +13

Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells

Chen Zhu, Zhili Song, Anlai Wang et al. · Frontiers in Immunology · 2020 · 110 citations · Full text

Discovery of NVP‐LEQ506, a Second‐Generation Inhibitor of Smoothened

Stefan Peukert, Feng He, Miao Dai et al. · ChemMedChem · 2013 · 88 citations

, , +15

Rows per page

1–5 of 30